Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Survival of pleural malignant mesothelioma in Italy: a population-based study.

Montanaro F, Rosato R, Gangemi M, Roberti S, Ricceri F, Merler E, Gennaro V, Romanelli A, Chellini E, Pascucci C, Musti M, Nicita C, Barbieri PG, Marinaccio A, Magnani C, Mirabelli D.

Int J Cancer. 2009 Jan 1;124(1):201-7. doi: 10.1002/ijc.23874.

2.

Survival of peritoneal malignant mesothelioma in Italy: a population-based study.

Mirabelli D, Roberti S, Gangemi M, Rosato R, Ricceri F, Merler E, Gennaro V, Mangone L, Gorini G, Pascucci C, Cavone D, Nicita C, Barbieri PG, Marinaccio A, Magnani C, Montanaro F.

Int J Cancer. 2009 Jan 1;124(1):194-200. doi: 10.1002/ijc.23866.

3.

Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006.

Barbieri PG, Marinaccio A, Ferrante P, Scarselli A, Pinelli V, Tassi G.

Tumori. 2012 Mar-Apr;98(2):215-9. doi: 10.1700/1088.11932.

PMID:
22677987
4.

Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988-2000: a population-based study.

Gorini G, De Gregorio G, Silvestri S, Chellini E, Cupelli V, Seniori Costantini A.

Eur J Cancer Prev. 2005 Jun;14(3):195-9.

PMID:
15901986
5.

Analysis of survival of mesothelioma cases in the Italian register (ReNaM).

Marinaccio A, Nesti M; Regional Operational Centers..

Eur J Cancer. 2003 Jun;39(9):1290-5.

PMID:
12763219
6.

A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.

Kataoka Y, Yamamoto Y, Otsuki T, Shinomiya M, Terada T, Fukuma S, Yamazaki S, Hirabayashi M, Nakano T, Fukuhara S.

Jpn J Clin Oncol. 2015 Jun;45(6):562-8. doi: 10.1093/jjco/hyv039. Epub 2015 Apr 2.

PMID:
25838292
7.

Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.

Baud M, Strano S, Dechartres A, Jouni R, Triponez F, Chouaid C, Forgez P, Damotte D, Roche N, RĂ©gnard JF, Alifano M.

J Thorac Cardiovasc Surg. 2013 May;145(5):1305-11. doi: 10.1016/j.jtcvs.2012.09.023. Epub 2012 Oct 13.

8.

Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.

Fusco V, Ardizzoni A, Merlo F, Cinquegrana A, Faravelli B, De Palma M, Chessa L, Nicolò G, Serra M, Capaccio A, et al.

Anticancer Res. 1993 May-Jun;13(3):683-9.

PMID:
8317897
9.

Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma.

Berardi R, Fiordoliva I, De Lisa M, Ballatore Z, Caramanti M, Morgese F, Savini A, Rinaldi S, Torniai M, Tiberi M, Ferrini C, Onofri A, Cascinu S.

Tumori. 2016 Mar-Apr;102(2):190-5. doi: 10.5301/tj.5000418. Epub 2016 Feb 12.

PMID:
26893272
10.

Malignant pleural mesothelioma: a population-based study of survival.

Milano MT, Zhang H.

J Thorac Oncol. 2010 Nov;5(11):1841-8. doi: 10.1097/JTO.0b013e3181f1cf2b.

11.

Survival after pleural malignant mesothelioma: a population-based study in Italy.

Magnani C, Viscomi S, Dalmasso P, Ivaldi C, Mirabelli D, Terracini B.

Tumori. 2002 Jul-Aug;88(4):266-9.

PMID:
12400973
12.

Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.

Damhuis RA, Khakwani A, De Schutter H, Rich AL, Burgers JA, van Meerbeeck JP.

Lung Cancer. 2015 Aug;89(2):212-7. doi: 10.1016/j.lungcan.2015.05.014. Epub 2015 May 22.

PMID:
26044908
13.

The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.

Giroux Leprieur E, Hirata T, Mo M, Chen Z, Okamoto J, Clement G, Li H, Wislez M, Jablons DM, He B.

Lung Cancer. 2014 Sep;85(3):465-71. doi: 10.1016/j.lungcan.2014.06.018. Epub 2014 Jun 30.

PMID:
25023662
14.

Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.

Frischknecht L, Meerang M, Soltermann A, Stahel R, Moch H, Seifert B, Weder W, Opitz I.

J Thorac Cardiovasc Surg. 2015 Jun;149(6):1539-46.e1. doi: 10.1016/j.jtcvs.2015.01.065. Epub 2015 Feb 12.

PMID:
25840756
15.

Prognostic factors of malignant mesothelioma of the pleura.

De Pangher Manzini V, Brollo A, Franceschi S, De Matthaeis M, Talamini R, Bianchi C.

Cancer. 1993 Jul 15;72(2):410-7.

16.

Diagnosis and prognostic factors in malignant pleural mesothelioma: a retrospective analysis of sixty-five patients.

Tammilehto L, Maasilta P, Kostiainen S, Appelqvist P, Holsti LR, Mattson K.

Respiration. 1992;59(3):129-35.

PMID:
1439223
17.

Prognostic factors for 100 patients with malignant pleural mesothelioma.

Gonlugur U, Gonlugur TE.

Arch Environ Occup Health. 2010 Apr-Jun;65(2):65-9. doi: 10.1080/19338240903390271.

PMID:
20439224
18.

Prognostic factors and survival in malignant pleural mesothelioma.

Van Gelder T, Damhuis RA, Hoogsteden HC.

Eur Respir J. 1994 Jun;7(6):1035-8.

19.

[Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].

Desoubeaux N, Bouvier V, Gervais R, Galateau-Salle F, Thibon P, Leplumey T, Herbert C, Lecherbonnier Y, Daviet JP, Letourneux M.

Rev Epidemiol Sante Publique. 2001 Dec;49(6):523-9. French.

PMID:
11845101
20.

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.

Linton A, Pavlakis N, O'Connell R, Soeberg M, Kao S, Clarke S, Vardy J, van Zandwijk N.

Br J Cancer. 2014 Oct 28;111(9):1860-9. doi: 10.1038/bjc.2014.478. Epub 2014 Sep 4.

Supplemental Content

Support Center